baber/WOPTO huggingface dataset:
Patent MX-2019004365-A (MX)
Title: Oral care implement.
Inventor: EDUARDO JIMENEZ
IPC: A46B17/06
Filed: 2016-10-19
Abstract: An oral care implement sanitization system that includes an oral care implement and a case for storing the oral care implement and activating a sanitization or sterilization procedure. The oral care implement may include tooth cleaning elements, a light source, and a first electrical coupling element operably coupled to the light source. The case may include a housing having a cavity for holding the oral care implement, a power source, and a second electrical coupling element operably coupled to the power source. When the oral care implement is positioned within the cavity of the housing of the case, the first and second electrical coupling elements are operably coupled together. Operable coupling of the first and second electrical coupling elements initiates, either immediately or upon the occurrence of some additional action, activation of the light source for sanitizing or sterilizing the tooth cleaning elements.
Patent MX-2019006567-A (MX)
Title: Systems, methods, and media for displaying interactive augmented reality presentations.
Inventor: GRISWOLD MARK A
IPC: G06T19/00
Filed: 2017-12-05
Abstract: Systems, methods, and media for displaying interactive augmented reality presentations are provided. In some embodiments, a system comprises: a plurality of head mounted displays, a first head mounted display comprising a transparent display; and at least one processor, wherein the at least one processor is programmed to: determine that a first physical location of a plurality of physical locations in a physical environment of the head mounted display is located closest to the head mounted display; receive first content comprising a first three dimensional model; receive second content comprising a second three dimensional model; present, using the transparent display, a first view of the first three dimensional model at a first time; and present, using the transparent display, a first view of the second three dimensional model at a second time subsequent to the first time based one or more instructions received from a server.
Patent MX-2019007614-A (MX)
Title: Nanoparticles for use for treating a neuronal disorder.
Inventor: LAURENT LEVY
IPC: A61N1/36
Filed: 2017-12-19
Abstract: The present invention relates to the medical field, in particular to the treatment of neurological disorders. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use in prevention or treatment of a neurological disease or at least one symptom thereof in a subject when the nanoparticle or nanoparticles' aggregate is exposed to an electric field, wherein the nanoparticle's or nanoparticles' aggregate's material is selected from a conductor material, a semiconductor material, an insulator material with a dielectric constant (eijk) equal to or above 200, and an insulator material with a dielectric constant (eijk) equal to or below 100. It further relates to compositions and kits comprising such nanoparticles and/or nanoparticles' aggregates as well as to uses thereof.
Patent MX-2019009583-A (MX)
Title: Water treatment.
Inventor: Andrew CANNON
IPC: C02F3/00
Filed: 2018-02-09
Abstract: A water treatment apparatus (1), the apparatus (1) comprises a fluid inlet (2), a first MBBR (4) and a second MBBR (5) and a fluid outlet (3), and a controller or control means (C1), wherein the first MBBR (4) and second MBBR (5) are connected in series such that water to be treated flows from the inlet (2) through the first MBBR (4) to the second MBBR (5) and thence to the outlet (3) and wherein the controller or control means (C1) is operable to change the flow direction such that water to be treated flows from the inlet (2) to the second MBBR (5) then to the first MBBR (4) and thence to the outlet (3).
Patent MX-2019011030-A (MX)
Title: Piston for use a syringe with specific dimensional ratio of a sealing structure.
Inventor: MIKKEL HETTING
IPC: A61M5/315
Filed: 2015-11-18
Abstract: The present invention relates to piston for use in an injector comprising a cylinder having a longitudinal axis and an inner wall, which piston has a deformable sealing element with a convex surface, which deformable sealing element when the piston is inserted in the cylinder abuts the inner wall of the cylinder at an abutting interface and seals an annular gap between the piston and the inner wall of the cylinder, the abutting interface and the deformable sealing element having axial dimensions parallel with the longitudinal axis, characterised in that the ratio between the axial dimension of the abutting interface and the axial dimension of the deformable sealing element is in the range between 0.01 and 0.2. In other aspects the invention relates to an injector comprising the piston and to the use in a disposable syringe of the piston. The piston can prevent refilling of a syringe.
Patent MX-2019012005-A (MX)
Title: Additive manufacturing based on fluid-fluid interface.
Inventor: ANDREW HUDSON
IPC: B29C64/124
Filed: 2018-04-06
Abstract: This document describes systems and method of embedded printing for additive manufacturing. A print material is printed into a support material. The print material and the support material each have a fluid phase and a solid phase. The print material transitions from the fluid phase to the solid phase based on a fluid-fluid interaction with the support material. One or more parameters of the support material can be adjusted to cause a diffusion rate of the print material into the support material during the fluid-fluid interaction to be less than a threshold value. Multiple print materials can be printed into the support material simultaneously.
Patent MX-2019014805-A (MX)
Title: Ready-to-drink coffee beverages and method of making thereof.
Inventor: GUILLERMO E NAPOLITANO
IPC: A23F5/14
Filed: 2018-08-16
Abstract: Ready to drink coffee beverages are provided. The beverage comprises coffee; medium chain triglycerides (MCT); high acyl gellan gum; plant-based protein; and buffer wherein coffee is 0.5-2.5 w/w%, and MCT is 5-10 w/w%. The beverage can be refrigerated and shelf-stable in a homogenous state for at least six months at 4, 20 and 30°C.
Patent MX-2019015039-A (MX)
Title: Hexavalent chromium free etch manganese vacuum evaporation system.
Inventor: BAUMAN MARK
IPC: C09K13/04
Filed: 2018-07-10
Abstract: Methods and systems for removing water from a manganese-based etchant bath are disclosed. Water is removed from the manganese-based etchant bath by transferring a portion of the manganese-based etchant bath to a vacuum evaporator for processing and transferring the concentrated portion of the manganese-based etchant bath back to the manganese-based etchant bath.
Patent MX-2020001502-A (MX)
Title: Concrete anchor driver tool.
Inventor: LANGDON JR ROBERT S
IPC: B25D17/00
Filed: 2016-09-02
Abstract: The disclosed concrete anchor driver tool is coupled to a rotary hammer drill to install a concrete anchor. The tool includes a rod having multi-faceted bolt head end, such as a hexagonal bolt head end, and a socket having a multi-faceted opening in the socket end of the socket. The socket is slipped over the rod and held against the bolt head end of the rod by a compressible spring. The concrete anchor driver tool is operated by coupling the concrete anchor driver tool to a rotary hammer drill, slipping the socket over the concrete anchor, and operating the drill in the hammer mode to hammer the concrete anchor bolt into the concrete. The rotary hammer drill is then put in rotate mode and used to rotate the concrete anchor driver tool rod, which rotates the socket, which, in turn, tightens the nut on the concrete anchor.
Patent MX-2020002929-A (MX)
Title: Developer replenishment system, method for attaching developer replenishment container, and developer replenishment unit.
Inventor: YOMODA NOBUYUKI
IPC: G03G15/08
Filed: 2018-09-21
Abstract: This developer replenishment container is attachable to and detachable from a developer receiving device that comprises a developer receiving section wherein a receiving port for receiving developer is formed, and comprises an engaged section 11b integrally displaceable with the developer receiving section. The developer replenishment container comprises a discharge section wherein a shutter opening for discharging developer accommodated in a developer accommodation section is formed. After the developer replenishment container is mounted to a prescribed position on the developer receiving device, an operation part 21 performs a prescribed operation to engage an engaging section 21d with the engaged section 11b, thereby causing the developer receiving section to be displaced such that the receiving port is in communication with the shutter opening.
Patent MX-2020003629-A (MX)
Title: Fermentative production of n-acetylneuraminic acid.
Inventor: JENNEWEIN STEFAN
IPC: C12P19/00
Filed: 2018-10-17
Abstract: EMPTY
Patent MX-2020006964-A (MX)
Title: Pharmaceutical composition comprising a cannabinoid.
Inventor: WILKHU JITINDER
IPC: A61K31/352
Filed: 2019-01-02
Abstract: The present invention relates to a novel cannabinoid oral pharmaceutical dosage form, based on a Type IV or Type IV-like formulation, as classified using the Lipid Formulation Classification System. The formulation is contained in a container. By Type IV-like, it is meant that the formulation comprises no oil, for example no triglycerides or mixed glycerides.
Patent MX-2020009145-A (MX)
Title: Methods for dispensing and adhering hot melt entrained polymers to substrates.
Inventor: FREEDMAN JONATHAN R
IPC: B29C48/08
Filed: 2018-09-05
Abstract: Disclosed are an entrained polymer or an entrained polymer composition, and a method for forming and adhering an entrained polymer structure to a substrate using the entrained polymer or an entrained polymer composition. The method includes providing a substrate configured to receive application of a molten entrained polymer. A particulate entrained polymer in molten form is applied in a predetermined shape, to a surface of the substrate, to form a solidified entrained polymer structure on the substrate. The entrained polymer includes a monolithic material formed of at least a base polymer and a particulate active agent. The surface of the substrate is compatible with the molten entrained polymer so as to thermally bond with it. In this way, the entrained polymer bonds to the substrate and solidifies upon sufficient cooling of the entrained polymer.
Patent MX-2020010029-A (MX)
Title: Updateable smart contracts.
Inventor: SRIVASTAVA NEERAJ
Filed: 2019-03-29
Abstract: A parent/child model for smart contracts enables the smart contracts to be updateable without compromising the immutability of the underlying data. As a first step, a parent smart contract (Client Contract) is deployed that stores any other contract that may be called using the contract address. Then, whenever a new child smart contract (Service Contract) is deployed, the parent smart contract is updated with the address of the new child smart contract so that the parent smart contract will be able to call the child smart contract. The structure of the child smart contract is known to the parent smart contract. For example, the number of inputs going into the child smart contract and the number of outputs coming out of the child smart contract are known to the parent smart contract before deployment of the parent smart contract, and the transaction data remains accessible without affecting the parent contract.
Patent MX-2020010964-A (MX)
Title: Antibody-drug conjugate.
Inventor: YOSHIDA MASAO
IPC: A61K31/4745
Filed: 2015-03-26
Abstract: Provided is an antibody-drug conjugate which can be used as an anti-tumor agent that has an excellent anti-tumor effect and is highly safe, said conjugate being characterized by being produced by binding an anti-tumor compound represented by formula (1) to an antibody through a linker having a structure represented by the formula: -L<sup>1</sup>-L<sup>2</sup>-L<sup>P</sup>-NH-(CH<sub>2</sub>)n <sup>1</sup>-L<sup>a</sup>-L<sup>b</sup>-L<sup>c</sup>- (wherein the antibody is bound at the terminal of L<sup>1</sup>, and the anti-tumor compound is bound at the terminal of L<sup>c</sup> in which the binding site of the anti-tumor compound is a nitrogen atom in an amino group located at position-1).
Patent MX-2021001574-A (MX)
Title: Extracellular vesicles for inhalation.
Inventor: MCCAULEY GERARD BERNARD
IPC: A61K9/00
Filed: 2019-08-09
Abstract: Vesicles, including exosomes, having a coating of a hydrophilic, neutral polymer such a PEG have an increased ability to form a suspension or colloid compared to uncoated vesicles. This enables the coated vesicles to be used to form aerosol droplets such that a liquid formulation containing vesicles can be used in a nebulizer for inhaled administration thereof. Such coated vesicles are also able to pass through mucus and can deliver their cargo into lung cells. Exosomes from mesenchymal stem cells can deliver additional proteins, miRs, mRNAs and other nucleic acid sequences to lung cells providing a regenerative gene therapy for CF, COPD lung cancer and other lung diseases.
Patent MX-2021003186-A (MX)
Title: Novel hydrogel conjugates.
Inventor: BISEK NICOLA
IPC: A61K47/60
Filed: 2019-09-25
Abstract: The present invention relates to conjugates comprising backbone moieties that are crosslinked via particular crosslinker moieties to which a plurality of drug moieties are covalently and reversibly conjugated. It also relates to their use as medicaments and their use in the diagnosis, prevention and treatment of diseases.
Patent MX-2021005146-A (MX)
Title: Compositions comprising oxidized cellulose.
Inventor: FAINGOLD OMRI
IPC: A61L31/04
Filed: 2019-10-30
Abstract: The present invention provides compositions comprised of oxidized cellulose (OC) and glycerol, with the ratio of glycerol to OC being at least about 0.5:1 w/w glycerol : OC and/or with the viscosity of the composition being at least 10% higher than that of the glycerol and lower than about 2.6X10<sup>9</sup> cP, with the total water content being less than about 8% w/w. Further provided is adhesion prevention powder comprised of OC having a carboxyl content of equal to below 18% characterized by high adhesion prevention potency. Uses of the compositions as hemostats or as adhesion prevention material, and methods for the preparation thereof are further provided herein.
Patent MX-2021006043-A (MX)
Title: Bin level monitoring system.
Inventor: SCHWARTZENTRUBER RANDALL
IPC: H04W4/12
Filed: 2019-07-31
Abstract: A bin level monitoring system bin level monitoring system comprising an optical sensor for sensing a feed level inside a feed bin, a circuit board communicatively connected to the sensor for receiving a level signal from the sensor and for processing the level signal to generate bin level data, a battery for powering the circuit board and sensor, an enclosure for enclosing the circuit board and a radio transmitter for transmitting the bin level data. The sensor may be a LIDAR sensor or a time-of-flight (ToF) sensor.
Patent MX-2021007692-A (MX)
Title: Anti-pd-1 binding proteins and methods of use thereof.
Inventor: JOHNSON DAVID SCOTT
IPC: C07K14/725
Filed: 2019-12-27
Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to PD-l and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
Patent MX-2021008081-A (MX)
Title: Treatment of sjogren's disease with nuclease fusion proteins.
Inventor: POSADA JAMES ARTHUR
IPC: A61K47/68
Filed: 2020-01-03
Abstract: The present disclosure provides methods for treating Sjogren's disease by administering nuclease fusion proteins. The methods of the disclosure are useful to treat symptoms associated with Sjogren's disease, including fatigue.
Patent MX-2021009091-A (MX)
Title: Techniques for efficiently performing subsequence-based encoding for a media title.
Inventor: GUO LIWEI
IPC: H04N21/2343
Filed: 2020-02-04
Abstract: In various embodiments, an interpolation-based encoding application encodes a first subsequence included in a media title at each encoding point included in a first set of encoding points to generate encoded subsequences. Subsequently, the interpolation-based encoding application performs interpolation operation(s) based on the encoded subsequences to estimate a first media metric value associated with a first encoding point that is not included in the first set of encoding points. The interpolation-based encoding application then generates an encoding recipe based on the encoded subsequences and the first media metric value. The encoding recipe specifies a different encoding point for each subsequence included in the media title. After determining that the encoding recipe specifies the first encoding point for the first subsequence, the interpolation-based encoding application encodes the first subsequence at the first encoding point to generate at least a portion of an encoded version of the media title.
Patent MX-2021010646-A (MX)
Title: 360â° assistance for qcs scanner with mixe d reality and machine learning technology.
Inventor: LANKEHANUMAIAH PAVAN TUMKUR
IPC: G06F3/048
Filed: 2020-03-06
Abstract: An apparatus, a method and a non-transitory machine-readable medium for providing 360Â° assistance for a quality control scanner with mixed reality and machine learning technology using an optical sensor, a display, a chatbot, a cloud service and a processor operably connected to the optical sensor and the display, wherein the processor receives diagnostic information from a server related to a field device in an industrial process control and automation system to identify and detects issues of the field device using optical sensor and guides a user to a location and a scanner part of the field device using the display to take steps or actions to resolve the issue; and connects to a cloud server to get modules of installation, commissioning, annual maintenance and training for a quality control system.
Patent MX-2021012221-A (MX)
Title: Cd73 inhibitor, preparation method therefor and application thereof.
Inventor: DENG HAIBING
IPC: C07H19/16
Filed: 2020-04-27
Abstract: A CD73 inhibitor having the structure represented by formula (I), a preparation method therefor and an application thereof. The series of compounds can be widely applied in the preparation of drugs for treating cancers or tumors that are at least partially mediated by CD73, autoimmune diseases and disorders, and metabolic diseases, in particular drugs for treating melanoma, colon cancer, pancreatic cancer, breast cancer, prostate cancer, lung cancer, leukemia, brain tumor, lymphoma, ovarian cancer, and Kaposi's sarcoma. A new generation of CD73 inhibitor drugs is expected to be developed.
Patent MX-2021014169-A (MX)
Title: Purification of oligosaccharides from a fermentation broth by using filtration.
Inventor: JENNEWEIN STEFAN
IPC: C07H1/08
Filed: 2020-04-29
Abstract: A method for the purification of an oligosaccharide, preferably a neutral human milk oligosaccharide (HMO) or a sialylated HMO, from a fermentation broth, the method comprising: - providing a fermentation broth which contains the oligosaccharide of interest, biomass, microbial cells and carbohydrates other than the oligosaccharide of interest; - removing the microbial cells from the fermentation broth, thereby providing a process stream; - subjecting the process stream to a first filtration step using a nanofiltration membrane, thereby providing a filtrate which contains the oligosaccharide of interest; - subjecting the filtrate to a second filtration step using a nanofiltration membrane, thereby providing a retentate which contains the oligosaccharide of interest; and - removing salts from the process stream using electrodialysis thereby providing a purified preparation of the oligosaccharide of interest.
Patent MX-2021014721-A (MX)
Title: Systems and methods for machine learning of voice attributes.
Inventor: EDWARDS ERIK
IPC: A61K35/741
Filed: 2020-06-01
Abstract: Systems and methods for machine learning of voice and other attributes are provided. The system receives input data, isolates predetermined sounds from isolated speech of a speaker of interest, summarizes the features to generate variables that describe the speaker, and generates a predictive model for detecting a desired feature of a person. Also provided are systems and methods for detecting one or more attributes of a speaker based on analysis of audio samples or other types of digitally-stored information (e.g, videos, photos, etc.).
Patent MX-2022001273-A (MX)
Title: Heterotandem bicyclic peptide complex.
Inventor: MUDD GEMMA
IPC: A61K38/12
Filed: 2020-07-30
Abstract: The present invention relates to a heterotandem bicyclic peptide complex which comprises a first peptide ligand, which binds to EphA2, conjugated via a linker to two second peptide ligands, which bind to CD137. The invention also relates to the use of said heterotandem bicyclic peptide complex in preventing, suppressing or treating cancer.
Patent MX-2022001410-A (MX)
Title: Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6- doxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide.
Inventor: MACBETH KYLE
IPC: A61K31/454
Filed: 2019-12-20
Abstract: Provided herein are formulations and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-l-oxoisoindolin-5-yl)methyl)-2,2-difluoroa cetamide or a stereoisomer or mixture of stereoisomers, pharmaceutically acceptable salt, tautomer, prodrug, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
Patent MX-2022003812-A (MX)
Title: Device and method for the non-invasive determination of analytes.
Inventor: EBERT DIETER
IPC: A61B5/05
Filed: 2020-09-17
Abstract: The present invention relates a device and a method for noninvasively determining an analyte in blood, in particular for noninvasively determining an analyte in capillary blood.
Patent MX-2022003814-A (MX)
Title: 4-quinolinone antibacterial compounds.
Inventor: GUILLEMONT JÉRÔME ÉMILE GEORGES
IPC: A61K31/519
Filed: 2020-09-29
Abstract: The present invention relates to the following compounds (I) wherein the integers are as defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of tuberculosis (e.g. in combination).
Patent MX-2022014002-A (MX)
Title: Oral powder mixture with small sized particles.
Inventor: WITTORFF HELLE
IPC: A61K9/00
Filed: 2021-04-30
Abstract: The invention relates to a powder mixture for oral delivery of active ingredients, the powder mixture comprising a population of particles and one or more active ingredients, the population of particles including at least two types of sugar alcohol particles, wherein: at least one of said at least two types of sugar alcohol particles comprising i) non-directly compressible (non-DC) sugar alcohol particles or ii) directly compressible (DC) sugar alcohol particles that are not granulated sugar alcohol particles; at least one of said at least two types of sugar alcohol particles having a particle size with more than 50% of the particles being below 250 microns; and at least one of said at least two types of sugar alcohol particles being present in an amount of at least 20% by weight of the powder mixture.